Novel strategies for immuno-oncology breakthroughs with cell therapy
Abstract Cell therapy has evolved rapidly in the past several years with more than 250 clinical trials ongoing around the world. While more indications of cellular therapy with chimeric antigen receptor - engineered T cells (CAR-T) are approved for hematologic malignancies, new concepts and strategi...
Saved in:
Main Authors: | Hongtao Liu (Author), Chongxian Pan (Author), Wenru Song (Author), Delong Liu (Author), Zihai Li (Author), Lei Zheng (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitative Approach to Explore Regulatory T Cell Activity in Immuno-Oncology
by: Alejandro Serrano, et al.
Published: (2024) -
Lung cancer - the role of immuno-oncology and the importance of pembrolizumab in its therapy
by: Jakub Jarosz, et al.
Published: (2023) -
Novel insights into voltage-gated ion channels: Translational breakthroughs in medical oncology
by: Minas Sakellakis, et al.
Published: (2024) -
Strategic Consensus on the Value of Immuno-Oncology in Portugal
by: . .
Published: (2016) -
Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review
by: Valeria Cognigni, et al.
Published: (2021)